E75.2 Category · further specificity required Other sphingolipidosis
ICD-10-CM E75.2 identifies “Other sphingolipidosis” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Excludes 11
adrenoleukodystrophy [Addison-Schilder] (E71.528)
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E75 · Disorders of sphingolipid metabolism and other lipid storage disorders
Excludes 12
- mucolipidosis, types I-III (E77.0-E77.1)
- Refsum's disease (G60.1)
More specific codes
E75.21Fabry (-Anderson) diseaseBillable / specificE75.22Gaucher diseaseBillable / specificE75.23Krabbe diseaseBillable / specificE75.24Niemann-Pick diseaseCategory · further specificity requiredE75.25Metachromatic leukodystrophyBillable / specificE75.26Sulfatase deficiencyBillable / specificE75.27Pelizaeus-Merzbacher diseaseBillable / specificE75.28Canavan diseaseBillable / specificE75.29Other sphingolipidosisBillable / specificOfficial index references
History
Code history
Latest recorded change · FY2024
Effective from
- Inherited rules changed
Other sphingolipidosis
Category — select a more specific code
CDC/NCHS · FY2024All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | Inherited rules changed |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.